7.600EUR-1.94%Mkt Cap: 32.88M EURP/E: InfinityLast update: 2026-06-01
Malin Corporation plc, together with its subsidiaries, operates as an investment company in Europe and North America. It engages in the investment in life sciences and healthcare companies targeting various therapeutic a…
Industry Peers
Drug Manufacturers - Specialty & Generic150.78BSEKP/E 166.4
58.93BTRY—
56.89BEURP/E 22.4
32.78BPLNP/E 21.4
23.20BUSDP/E 20.2
18.39BUSD—
16.21BUSDP/E 24.8
13.00BTRY—
Indicators:|
Key Statistics
Company
Market Cap32.88M EUR
Enterprise Value20.70M EUR
Revenue (TTM)—
Gross Profit—
Net Income (TTM)0 EUR
Revenue/Share—
Last Price7.600 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2
CountryIE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)Infinity
P/E (Forward)-64.58
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.87
EPS (TTM)0.00
EPS (Forward)-0.12
52W Range
7.00026% of range9.300
52W High9.300 EUR
52W Low7.000 EUR
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE0.00%
ROA0.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.30M EUR
CapEx (TTM)—
FCF Margin—
FCF Yield-2.78%
Net Debt-12.90M EUR
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.00
Current Ratio16.13
Quick Ratio16.13
Book Value/Sh8.904 EUR
Cash/Share2.976 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)15.50 EUR
Target Range15.50 EUR – 15.50 EUR
# Analysts1
Ownership
Shares Out.4.33M
Float902.92K
Insiders29.96%
Institutions35.00%
Technical
SMA 507.813 (-2.7%)
SMA 2007.942 (-4.3%)
Beta0.41
S&P 52W Chg27.94%
Avg Vol (30d)318
Avg Vol (10d)293
Technical Indicators
RSI (14)48.8
MACD-0.0628
MACD Signal-0.0500
MACD Hist.-0.0128
BB Upper8.184 EUR
BB Middle7.793 EUR
BB Lower7.401 EUR
BB Width10.04%
ATR (14)0.0947 EUR
Vol Ratio (20d)3.13x